Literature DB >> 17264762

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.

Sebastiano Buti1, Matteo Riccò, Matteo Dalla Chiesa, Bruno Copercini, Gianluca Tomasello, Matteo Brighenti, Rodolfo Passalacqua.   

Abstract

We report the case of a 64-year-old patient who developed autoimmune hemolytic anemia with thrombocytopenia and acute renal failure shortly after the infusion of the 11th cycle of adjuvant chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX 4), and was successfully treated by means of plasmapheresis, corticosteroids and dialysis. To the best of our knowledge, only seven other cases have been described in the literature, but we believe this serious adverse event induced by oxaliplatin is more frequent than this would suggest.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17264762     DOI： 10.1097/CAD.0b013e3280102f4b

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


  7 in total

Review 1.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

2.  A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

Authors:  Haifaa Dbouk; Simon Mentha; Deborah Mukherji; Jean Lee; Ali Haydar; Ali Shamseddine; Eileen M O'Reilly; Leonard Saltz; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2014-03

3.  A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.

Authors:  Isao Ito; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Kaoru Yasuda; Takenori Ozaki; Tomoki Kosugi; Yoshinari Yasuda; Waichi Sato; Naotake Tsuboi; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2012-03-27       Impact factor: 2.801

4.  Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literature.

Authors:  Shweta Kurian; Jessica Macintyre; Muzammil Mushtaq; Caio Max Rocha-Lima; Yeon Ahn
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

Review 5.  Kidney injury and disease in patients with haematological malignancies.

Authors:  Frank Bridoux; Paul Cockwell; Ilya Glezerman; Victoria Gutgarts; Jonathan J Hogan; Kenar D Jhaveri; Florent Joly; Samih H Nasr; Deirdre Sawinski; Nelson Leung
Journal:  Nat Rev Nephrol       Date:  2021-03-30       Impact factor: 28.314

6.  Severe acute tubular necrosis observed subsequent to oxaliplatin administration.

Authors:  Niall Filewod; Mark L Lipman
Journal:  Clin Kidney J       Date:  2013-12-29

7.  Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.

Authors:  Eric L Tam; Padma L Draksharam; Jennifer A Park; Gurinder S Sidhu
Journal:  Case Rep Oncol Med       Date:  2019-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.